More Biome Australia Ltd news
Biome Australia LtdASX: BIO

Positive Results on Clinical Development of BMB18

Jan 29, 2025 at 9:44 PM EST · Issued by Biome Australia Ltd

Filed with ASX · Jan 29, 2025 at 9:44 PM EST · 5 pages · English

On 6ix: 6ix.com/news/positive-results-on-clinical-development-of-bmb18

Watch Biome Australia's latest call↗Biome Australia (ASX:BIO) Q1 2026 Earnings Call · Replay · Oct 22, 2025Read the transcript of Biome Australia (ASX:BIO) Q1 2026 Earnings Call↗

Biome Australia Ltd on 6ix

Story so far

  • Biome Clinical Development UpdateFeb 21, 2022

Earlier from Biome Australia

  • Biome Increases Australian DistributionJan 23, 2025
  • Biome reports record quarterly sales revenue for Q2 FY25Jan 5, 2025
  • Q2 Revenue GuidanceNov 26, 2024
  • Biome Strain Development Program SuccessNov 13, 2024
  • Business and International Market UpdateNov 12, 2024

Later from Biome Australia

  • Biome Secures FaBA Co-investment for IP DevelopmentFeb 4, 2025
  • Biome First Half FY25 Results and HighlightsFeb 17, 2025
  • Biome reports strong sales revenue for Q3 FY25Apr 1, 2025
  • Biome secures $5 million debt facilities with NABApr 2, 2025
  • Activated Probiotics New Product LaunchesApr 29, 2025
All Biome Australia news releases↗

Follow Biome Australia into a list and get an email when it puts out news.

Follow Biome Australia
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer